Articles November 14, 2023 “10 Tips for Evaluating Patent Applications Prepared by Outside Counsel,” Association of Corporate Counsel
Articles November 14, 2023 Harness IP’s Joel R. Samuels Featured in Super Lawyers Magazine’s “Choosing the Open Door”
Articles October 8, 2023 “Recent Trademark Decision Serves as Lesson for Cannabis Companies,” Cannabis Business Executive
Articles September 29, 2023 “The INFORM Act: Will Counterfeiters Scatter Like Cockroaches Under a Light?” Total Retail
Articles September 8, 2023 Chris Cauble’s “Focusing Solely on U.S. Patents Can Be a Risky Move. Here’s Why,” Published by Medical Device News
Articles August 25, 2023 “Has LIV Golf ‘Fallen’ Into a Sticky Trademark Infringement Web?” – Harness IP’s Joe Walsh Pens Law360 Article
Articles August 22, 2023 Michael Teich’s “AI Voice Cloning – and Its Misuse – Has Opened a Pandora’s Box of Legal Issues: Here’s What to Know” Published on IP Watchdog
Articles August 2, 2023 “Lexicography: The Ultimate Superpower” – Harness IP’s Bryan Wheelock in The Patent Lawyer
Articles August 1, 2023 “4 Pitfalls to Avoid When Vying for Medical Device Funding” – Harness IP’s Chris Miller in Medical Device and Diagnostic Industry Online
Articles July 12, 2023 “Don’t Get Cheesed – Protect Your Video Game’s Intellectual Property” – Harness IP’s Matt Cutler in Licensing Journal
Articles May 25, 2023 “From FTC to SCOTUS, Amgen’s Woes are Potential ‘Game Changers’ for the Industry” PharmaVoice
Articles May 14, 2023 U.S. & Unitary Patent: “Low Barrier to Pan-Europe Rights” – Harness Special Counsel John White Interviewed by Kluwer Patent Blog
Articles March 31, 2023 “US Supreme Court Weighs Biologics Patents in Amgen vs. Sanofi Case,” PharmTech and BioPharm International
Articles March 29, 2023 Au contraire, mon frere! It’s our Gruyere – Cheese trademark case offers lessons for attorneys, The Detroit Legal News
Articles March 28, 2023 “SCOTUS to Decide ‘Fundamental Change’ in Biologics Patents with Fate of Amgen v. Sanofi,” PharmaVoice